Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases
Open Access
- 14 August 2019
- journal article
- review article
- Published by Springer Nature in CNS Drugs
- Vol. 33 (9) , 883-904
Abstract
The most common neurodegenerative diseases are Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease, frontotemporal lobar degeneration, and the motor neuron diseases, with AD affecting approximately 6% of people aged 65 years and older, and PD affecting approximately 1% of people aged over 60 years. Specific proteins are associated with these neurodegenerative diseases, as determined by both immunohistochemical studies on post-mortem tissue and genetic screening, where protein misfolding and aggregation are key hallmarks. Many of these proteins are shown to misfold and aggregate into soluble non-native oligomers and large insoluble protein deposits (fibrils and plaques), both of which may exert a toxic gain of function. Proteotoxicity has been examined intensively in cell culture and in in vivo models, and clinical trials of methods to attenuate proteotoxicity are relatively new. Therapies to enhance cellular protein quality control mechanisms such as upregulation of chaperones and clearance/degradation pathways, as well as immunotherapies against toxic protein conformations, are being actively pursued. In this article, we summarize the common pathophysiology of neurodegenerative disease, and review therapies in early-phase clinical trials that target the proteotoxic component of several neurodegenerative diseases.Keywords
Funding Information
- Canadian Institutes of Health Research (2682)
- Alberta Prion Research Institute (PTM13007)
This publication has 253 references indexed in Scilit:
- The Synaptic Accumulation of Hyperphosphorylated Tau Oligomers in Alzheimer Disease Is Associated With Dysfunction of the Ubiquitin-Proteasome SystemThe American Journal of Pathology, 2012
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin SynthesisNeuron, 2012
- Protein misfolding and aggregation in cataract disease and prospects for preventionTrends in Molecular Medicine, 2012
- Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in ratNeurobiology of Disease, 2011
- Theories of the Pathogenesis of Inclusion Body MyositisCurrent Rheumatology Reports, 2010
- Sarcoplasmic redistribution of nuclear TDP‐43 in inclusion body myositisMuscle & Nerve, 2009
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the ElderlyArchives of Neurology, 2008
- Changes in the regulation of heat shock gene expression in neuronal cell differentiationCell Stress and Chaperones, 2008
- Hsp70 Gene Transfer by Adeno-associated Virus Inhibits MPTP-Induced Nigrostriatal Degeneration in the Mouse Model of Parkinson DiseaseMolecular Therapy, 2005
- Role and Regulation of Starvation-Induced Autophagy in the Drosophila Fat BodyDevelopmental Cell, 2004